
Axonis Therapeutics
Operator of a neuro-focused biotechnology company intended to develop medicines targeting a critical mediator of inhibitory neurotransmission in the brain. The company has developed a proprietary neur...
Valuation
$0
Share Price
N/A
Total Raised
$149.6M
Last Round
N/A